Meaning
Short-term funding provided by company owners to meet immediate working capital needs is treated as a liability on the corporate balance sheet. Often referred to as shareholder advances, these cash injections are structured as loans rather than equity contributions to allow for straightforward repayment once the cash flow of the business improves. They provide a flexible way to support the company without changing the ownership structure.
Financial Injection
Providing these funds requires a clear written agreement specifying the terms of the loan to avoid disputes with later investors. The company receives the cash immediately to cover urgent expenses, while the founder gains a right to future repayment. This temporary support is common in the pre-revenue phase of a startup before institutional funding is secured.
Tax Treatment
Documenting the advance as a formal loan with a reasonable interest rate is necessary to satisfy tax authorities. If the transaction lacks documentation or fails to charge interest, tax regulators may recharacterize the loan as a capital contribution, which complicates future repayment. This recharacterization can result in unexpected tax liabilities for both the company and the individual founder.
Repayment Priority
Settling these loans usually occurs when the company raises a formal round of equity or achieves consistent profitability. However, new investors often require that these internal debts be converted into equity or subordinated to their new capital to ensure their funds are used to grow the business rather than repay founders. This subordination protects external capital but delays the return of the founder’s personal cash, which can create tension if the founder expected immediate repayment upon the closing of the financing round.